PRESS RELEASE

Q3 2023 — Press release

Q3 2023PDF · 8 pages192 KB
Media 	contact 	Investor 	contact
Timothy 	Barello, 	212.299.2256 	Adam 	Minick, 	312.340.8365
Laurie Bischel, 312.648.8698 	investors@cmegroup.com
news@cmegroup.com 	CME-G
www.cmegroup.com/media-
room.html
FOR IMMEDIATE RELEASE
CME Group Inc. Reports Third-Quarter 2023 Financial Results
CHICAGO, October 25, 2023 - CME Group Inc. (NASDAQ: CME) today reported
financial results for the third quarter of 2023.
The company reported revenue of $1.3 billion and operating income of $820 million for
the third quarter of 2023. Net income was $750 million and diluted earnings per common share
were $2.06. On an adjusted basis, net income was $818 million and diluted earnings per
common share were $2.25. Financial results presented on an adjusted basis for the third
quarter of 2023 and 2022 exclude certain items, which are detailed in the reconciliation of non-
GAAP results.1
"CME Group delivered its ninth consecutive quarter of double-digit growth in adjusted
earnings per share and a 9% increase in revenue as market participants continued turning to
our markets to mitigate their business risks amid accelerating geopolitical uncertainty," said
CME Group Chairman and Chief Executive Officer Terry Duffy. "This was a particularly strong
quarter, with interest rate volume increasing 6%, driven by an 18% rise in Treasury futures ADV
and records in our Ultra 10-Year and Ultra T-Bond futures. We also generated significant
growth across agricultural, energy and options products."
Third-quarter 2023 average daily volume (ADV) was 22.3 million contracts. Non-U.S.
ADV reached 6.5 million contracts, up 7% from third-quarter 2022, including 16% growth in
interest rates and double-digit growth across agricultural, energy and metals products.
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of
GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.
-more-

-- 1 of 8 --

Page 	2
Clearing and transaction fees revenue for third-quarter 2023 totaled $1.1 billion. The
total average rate per contract was $0.707. Market data revenue totaled $168 million for third-
quarter 2023.
As of September 30, 2023, the company had approximately $2.5 billion in cash
(including $150 million deposited with Fixed Income Clearing Corporation, which is included in
other current assets) and $3.4 billion of debt. The company paid dividends of approximately
$400 million during the third quarter of 2023. The company has returned over $22 billion to
shareholders in the form of dividends since the implementation of the variable dividend policy in
early 2012.
CME Group will hold a Q&A conference call to discuss third-quarter 2023 results
at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on
the Investor Relations section of CME Group’s website at www.cmegroup.com. An
archived recording will be available for up to two months after the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients
to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data - empowering
market participants worldwide to efficiently manage risk and capture opportunities. CME Group
exchanges offer the widest range of global benchmark products across all major asset classes based
on 	interest rates, 	equity indexes, 	foreign exchange, 	energy, 	agricultural products 	and 	metals. The
company offers futures and options on futures trading through the 	CME Globex® platform, fixed income
trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of
the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are
trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of
Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are
trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc.
BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. The
S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”,
“SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®,
DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark
Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc.
Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by
S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products.
All other trademarks are the property of their respective owners.
-more-

-- 2 of 8 --

Page 	3
Statements in this press release that are not historical facts are forward-looking statements. These
statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are
difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied
in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking
statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of
new information, future events or otherwise. Among the factors that might affect our performance are increasing
competition by foreign and domestic entities, including increased competition from new entrants into our markets
and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our
ability to complete the development, implementation and maintenance of the enhanced functionality required by
our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our
ability to continue introducing competitive new products and services on a timely, cost-effective basis, including
through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products
and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain
existing customers at substantially similar trading levels, develop strategic relationships and attract new
customers; our ability to expand and globally offer our products and services; changes in regulations, including the
impact of any changes in laws or government policies with respect to our products or services or our industry, such
as any changes to regulations and policies that require increased financial and operational resources from us or our
customers; the costs associated with protecting our intellectual property rights and our ability to operate our
business without violating the intellectual property rights of others; decreases in revenue from our market data as a
result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due
to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer
receives member or non-member fees or participates in one of our various incentive programs) and the impact of
our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect
us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity
requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk
management programs to effectively monitor and manage our risks, including our ability to prevent errors and
misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual
property assets; our dependence on third-party providers and exposure to risk through third parties, including risks
related to the performance, reliability and security of technology used by our third-party providers and third party
providers that our clients rely on; volatility in commodity, equity and fixed income prices, and price volatility of
financial benchmarks and instruments such as interest rates, credit spreads, equity indices, fixed income
instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of
the capital and credit markets and the impact of economic conditions on the trading activity of our current and
potential customers; our ability to accommodate increases in contract volume and order transaction traffic and to
implement enhancements without failure or degradation of the performance of our trading and clearing systems;
our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks,
control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances,
including those associated with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices
LLC) in index services and in trade processing/post trade services (OSTTRA), our primary data distribution partners’
actions and our partnership with Google Cloud; variances in earnings on cash accounts and collateral that our
clearing house holds for its clients; impact of CME Group pricing and incentive changes; impact of aggregation
services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms
of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness
to allow us to continue to invest in our business; industry, channel partner and customer consolidation; decreases in
trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions
and/or repeal of the 60/40 tax treatment of such transactions; our ability to maintain our brand and reputation;

-- 3 of 8 --

Page 	4
and the unfavorable resolution of material legal proceedings. For a detailed discussion and additional information
concerning these and other factors that might affect our performance, see our other recent periodic filings,
including our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the Securities and
Exchange Commission ("SEC") on February 27, 2023, under the caption "Risk Factors".
# # #
23-83

-- 4 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
September 30, 2023 	December 31, 2022
ASSETS
Current 	Assets:
Cash and cash equivalents 	$ 	2,300.2 	$ 	2,720.1
Marketable 	securities 	104.1 	96.0
Accounts 	receivable, 	net 	of 	allowance 	558.4 	483.2
Other 	current 	assets 	(includes 	$5.1 	and 	$4.9 	in 	restricted 	cash) 	622.0 	529.8
Performance 	bonds 	and 	guaranty 	fund 	contributions 	87,192.1 	135,249.2
Total current assets 	90,776.8 	139,078.3
Property, net of accumulated depreciation and amortization 	417.3 	455.5
Intangible assets—trading products 	17,175.3 	17,175.3
Intangible assets—other, net 	3,095.4 	3,269.7
Goodwill 	10,477.6 	10,482.5
Other assets (includes $0.0 and $0.1 in restricted cash) 	3,655.8 	3,714.4
Total Assets 	$ 	125,598.2 	$ 	174,175.7
LIABILITIES AND EQUITY
Current 	Liabilities:
Accounts payable 	$ 	53.8 	$ 	121.4
Short-term 	debt 	— 	16.0
Other 	current 	liabilities 	634.6 	2,300.9
Performance bonds and guaranty fund contributions 	87,192.1 	135,249.2
Total current liabilities 	87,880.5 	137,687.5
Long-term debt 	3,424.7 	3,422.4
Deferred income tax liabilities, net 	5,332.7 	5,361.1
Other 	liabilities 	808.7 	826.0
Total Liabilities 	97,446.6 	147,297.0
Total CME Group Shareholders’ Equity 	28,151.6 	26,878.7
Total Liabilities and Equity 	$ 	125,598.2 	$ 	174,175.7

-- 5 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
September 30,
Nine Months Ended,
September 30,
2023 	2022 	2023 	2022
Revenues
Clearing and transaction fees 	$ 	1,085.5 	$ 	998.6 	$ 	3,404.0 	$ 	3,161.3
Market data and information services 	167.6 	154.3 	496.5 	457.7
Other 	84.7 	74.9 	239.1 	192.6
Total Revenues 1,337.8 	1,227.8 	4,139.6 	3,811.6
Expenses
Compensation and benefits 	205.5 	189.6 	615.7 	560.1
Technology 	55.6 	46.8 	160.2 	138.6
Professional 	fees 	and 	outside 	services 	32.2 	35.1 	108.3 	98.9
Amortization of purchased intangibles 	57.2 	55.5 	171.0 	171.0
Depreciation and amortization 	31.1 	34.5 	95.3 	101.0
Licensing and other fee agreements 	79.5 	83.6 	242.4 	247.6
Other 	56.5 	43.9 	174.2 	146.8
Total Expenses 	517.6 	489.0 	1,567.1 	1,464.0
Operating Income 	820.2 	738.8 	2,572.5 	2,347.6
Non-Operating Income (Expense)
Investment 	income 	1,272.5 	686.2 	4,198.4 	1,046.2
Interest and other borrowing costs 	(39.6) 	(40.4) 	(119.7) 	(122.8)
Equity in net earnings of unconsolidated subsidiaries 	76.8 	76.5 	230.1 	237.1
Other non-operating income (expense) 	(1,155.6) 	(581.1) 	(3,733.7) 	(845.1)
Total Non-Operating Income (Expense) 	154.1 	141.2 	575.1 	315.4
Income before Income Taxes 	974.3 	880.0 	3,147.6 	2,663.0
Income tax provision 	224.1 	200.4 	736.0 	609.9
Net Income 	$ 	750.2 	$ 	679.6 	$ 	2,411.6 	$ 	2,053.1
Net Income Attributable to Common Shareholders of CME
Group 	$ 	740.8 	$ 	671.1 	$ 	2,381.3 	$ 	2,027.2
Earnings per Share Attributable to Common Shareholders
of CME Group:
Basic 	$ 	2.06 	$ 	1.87 	$ 	6.63 	$ 	5.65
Diluted 	2.06 	1.87 	6.62 	5.64
Weighted Average Number of Common Shares:
Basic 	359,020 	358,715 	358,965 	358,655
Diluted 	359,619 	359,288 	359,448 	359,206

-- 6 of 8 --

CME Group Inc. and Subsidiaries
Quarterly Operating Statistics
3Q 	2022 	4Q 	2022 	1Q 	2023 	2Q 	2023 	3Q 	2023
Trading Days 64 	63 	62 	62 	63
Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
Product 	Line 	3Q 	2022 	4Q 	2022 	1Q 	2023 	2Q 	2023 	3Q 	2023
Interest rates 	10,357 	9,832 	14,490 	11,273 	10,967
Equity indexes 	7,445 	7,465 	7,303 	6,216 	6,353
Foreign exchange 	1,091 	1,000 	969 	898 	942
Energy 	1,837 	1,829 	2,083 	2,104 	2,126
Agricultural commodities 	1,208 	1,171 	1,379 	1,752 	1,433
Metals 	498 	508 	649 	612 	528
Total 	22,437 	21,803 	26,873 	22,855 	22,349
Venue
CME 	Globex 	21,021 	20,279 	24,171 	20,907 	20,838
Open outcry 	704 	746 	1,623 	1,124 	713
Privately negotiated 	711 	778 	1,080 	825 	797
Total 	22,437 	21,803 	26,873 	22,855 	22,349
Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
Product 	Line 	3Q 	2022 	4Q 	2022 	1Q 	2023 	2Q 	2023 	3Q 	2023
Interest rates 	$ 	0.479 	$ 	0.500 	$ 	0.495 	$ 	0.505 	$ 	0.508
Equity indexes 	0.524 	0.535 	0.595 	0.644 	0.625
Foreign exchange 	0.729 	0.756 	0.790 	0.800 	0.791
Energy 	1.140 	1.181 	1.300 	1.347 	1.324
Agricultural commodities 	1.351 	1.356 	1.349 	1.356 	1.328
Metals 	1.520 	1.519 	1.517 	1.487 	1.492
Average RPC 	$ 	0.631 	$ 	0.651 	$ 	0.664 	$ 	0.724 	$ 	0.707
1. ADV and RPC includes futures and options on futures only.
CME Group Inc. and Subsidiaries

-- 7 of 8 --

Reconciliation 	of 	GAAP 	to 	non-GAAP 	Measures
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
September 30,
Nine Months Ended,
September 30,
2023 	2022 	2023 	2022
Net Income 	$ 	750.2 	$ 	679.6 	$ 	2,411.6 	$ 	2,053.1
Restructuring and severance 	12.6 	— 	14.9 	10.2
Amortization of purchased intangibles(1) 	70.7 	68.5 	211.3 	206.4
Strategic transaction-related costs (credits) 	— 	1.2 	(2.2) 	3.4
Foreign exchange transaction (gains) losses 	(1.9) 	(10.5) 	(0.1) 	(23.6)
Unrealized and realized (gains) losses on investments 	2.0 	(1.1) 	(71.8) 	(4.6)
Unrealized and realized (gains) losses on assets 	— 	0.7 	0.4 	0.7
Debt costs related to refinancing 	— 	— 	— 	7.7
Trading floor enhancements 	— 	— 	— 	4.8
Litigation Matters or Settlements 	2.0 	— 	2.0 	—
Income 	tax 	effect 	related 	to 	above 	(17.6) 	(11.3) 	(28.6) 	(40.1)
Other 	income 	tax 	items 	— 	(8.0) 	(0.8) 	(16.2)
Adjusted Net Income 	$ 	818.0 	$ 	719.1 	$ 	2,536.7 	$ 	2,201.8
Adjusted Net Income Attributable to Common Shareholders of CME
Group 	$ 	807.8 	$ 	710.0 	$ 	2,504.8 	$ 	2,174.1
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic 	$ 	2.06 	$ 	1.87 	$ 	6.63 	$ 	5.65
Diluted 	2.06 	1.87 	6.62 	5.64
Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:
Basic 	$ 	2.25 	$ 	1.98 	$ 	6.98 	$ 	6.06
Diluted 	2.25 	1.98 	6.97 	6.05
Weighted Average Number of Common Shares:
Basic 	359,020 	358,715 	358,965 	358,655
Diluted 	359,619 	359,288 	359,448 	359,206
Preferred shares(2) 	4,584 	4,584 	4,584 	4,584
1. Includes $11.1 million of amortization of purchased intangibles (net of tax) at OSTTRA and $2.5 million of amortization of
purchased intangibles at S&P Dow Jones Indices LLC, reported in Equity in net earnings of unconsolidated subsidiaries on the
Consolidated Statements of Income.
2. Preferred shares have similar rights as common shares without voting rights.
23-83	23-83

-- 8 of 8 --